monitoraeo
AEO Rankings · Healthcare

AEO for regulatory affairs consultancies: AI search visibility ranking

How AI search engines rank regulatory affairs consultancies by visibility and citations. 20 brands measured quarterly across Google AI Mode: which brands the AI names in answers, which domains it cites as sources, and how the leaders compare. Regulatory affairs consultancies helping life sciences and medtech teams navigate submissions, quality systems, labeling, strategy, and global compliance milestones. Composite score: 70% visibility (% of AI answers naming the brand) + 30% citation rate (% citing the brand's domain). Full methodology →

6%
Avg visibility across category
6%
Avg citation rate
20/20
Brands successfully audited
X LinkedIn

When evaluating regulatory affairs consultancies, AI engines frequently identify ProPharma as the leader in the field. ProPharma stands out with a notable visibility percentage of 50. Other top brands include Parexel and IQVIA, which also receive recognition but to a lesser extent. These brands are widely recommended due to their extensive expertise and industry credibility.

The visibility and rankings of these consultancies are strongly influenced by the top cited sources, such as biobostonconsulting.com, elexes.com, and jjccgroup.org. These domains are recognized for offering in-depth analyses and expert reviews. If aggregator sites predominately feature a brand, it suggests a strong reputation among industry experts, thus solidifying its position in AI recommendations.

Buyers should consider the AI engines' valuation of recent reviews and third-party validation when choosing from the list. A consultancy's high ranking often reflects its consistent output of current, expert-backed content. Prioritize brands that demonstrate topical authority and have strong endorsements within the specific subcategory of regulatory affairs, as these are indicators of reliability and expertise.

At a glance

Category leader ProPharma 50% visibility · named in 4 of 8 AI answers
Most cited brand ProPharma 62% citation rate · the AI's most-trusted source brand in regulatory affairs consultancies
Top cited domain biobostonconsulting.com Referenced by AI across the regulatory affairs consultancies query set — the highest-leverage PR target in this category
Visibility spread 50pp Gap between top and bottom of the ranking · 17 brands at 0% (invisible to the AI)

What we observed in this category

ProPharma leads the regulatory affairs consultancies category with a composite score of 53.8, built on 50.0% visibility and 62.5% citation rate. The next closest brands, Parexel and IQVIA, score 30.0 and 26.2 respectively, meaning ProPharma's composite score is nearly double that of its nearest rival. That gap is significant because it reflects dominance on both dimensions simultaneously, not a trade-off, making ProPharma the only brand in this category that Google AI Mode treats as both prominent and credible.

Parexel and IQVIA share identical visibility at 37.5%, but their citation rates diverge sharply: Parexel is cited 12.5% of the time while IQVIA records 0.0%. MCRA presents the inverse pattern, with 0.0% visibility but a 25.0% citation rate, suggesting Google AI Mode references MCRA content as a source without surfacing the brand by name in responses. This named-versus-trusted split means buyers may encounter MCRA-sourced information without MCRA being identified, a structural disadvantage for brand recognition.

Google AI Mode is the top engine for every brand in this dataset, indicating the audit is concentrated on a single engine. The top cited sources include several brands not ranked in the top 10, such as biobostonconsulting.com, elexes.com, lachmanconsultants.com, and umbrex.com, alongside propharmagroup.com and freyrsolutions.com. This suggests AI Mode is anchoring on a broader pool of specialist and niche consultancy websites as reference material, rather than defaulting exclusively to the largest CRO or regulatory brands.

Movers & shakers since last refresh

Biggest visibility risers

  • ProPharma 25% → 50% · rank #1 → #1
    +25pp
  • IQVIA 12% → 38% · rank #3 → #3
    +25pp
  • Parexel 25% → 38% · rank #2 → #2
    +12pp

Biggest visibility fallers

  • NAMSA 12% → 0% · rank #4 → #7
    -12pp
  • Pharmalex 12% → 0% · rank #5 → #8
    -12pp

The AEO ranking

# Brand Visibility Citation Top engine
1
propharmagroup.com
50% 62% Google AI Mode

ProPharma's 50.0% visibility and 62.5% citation rate both exceed the category average of 6.2% by a factor of roughly eight, making it the clear category leader by a wide margin.

2
parexel.com
38% 12% Google AI Mode

Parexel matches IQVIA on visibility at 37.5% but holds a 12.5% citation rate versus IQVIA's 0.0%, giving it a composite score of 30.0 compared to IQVIA's 26.2.

3
iqvia.com
38% 0% Google AI Mode

IQVIA gained 25 visibility points in the latest period but records zero citations, meaning AI Mode surfaces the brand by name yet never links to its domain as a reference.

4
mcra.com
0% 25% Google AI Mode

MCRA has 0.0% visibility but a 25.0% citation rate, the highest citation-to-visibility imbalance in the top five, indicating its content is used as a source without the brand being named.

5
freyrsolutions.com
0% 12% Google AI Mode

Freyr Solutions sits at rank five with a composite score of 3.8, zero visibility, and a 12.5% citation rate, and its domain appears directly in the top cited sources list for the category.

6
iconplc.com
0% 12% Google AI Mode
7
namsa.com
0% 0% Google AI Mode
8
pharmalex.com
0% 0% Google AI Mode
9
syneoshealth.com
0% 0% Google AI Mode
10
rqmplus.com
0% 0% Google AI Mode
11
mmsholdings.com
0% 0% Google AI Mode
12
genpact.com
0% 0% Google AI Mode
13
veristat.com
0% 0% Google AI Mode
14
dlrcgroup.com
0% 0% Google AI Mode
15
qbdgroup.com
0% 0% Google AI Mode
16
bluereg.com
0% 0% Google AI Mode
17
argintinternational.com
0% 0% Google AI Mode
18
productlife-group.com
0% 0% Google AI Mode
19
clinilabs.com
0% 0% Google AI Mode
20
voisinconsulting.com
0% 0% Google AI Mode

Sources AI engines trust in this category

Across the 8 buyer-intent queries we ran on regulatory affairs consultancies, these are the domains Google AI Mode cited most often. If you're not on this list — or if your competitors are — that's a concrete PR / linkbuilding target.

biobostonconsulting.comelexes.comjjccgroup.orgpropharmagroup.comlachmanconsultants.comumbrex.comfreyrsolutions.comlinkedin.com

How to read this AEO ranking

Four things worth knowing before you act on the numbers above. These are the same definitions across every industry page — for category-specific observations, see the What we observed section above (where available) and the per-brand insights inline in the ranking.

Visibility = being named

A brand's visibility % is the share of AI answers that mention it by name in the response prose. This is who AI engines actively recommend to the buyer. More on visibility →

Citation rate = being trusted

Citation rate is the share of AI answers that include the brand's domain as a clickable source link. This is what the AI treats as authoritative evidence, different from being named. More on citation rate →

Top engine differs by brand

The "top engine" column shows which AI surface each brand performs best on. Big gaps between a brand's score across engines usually points to specific content or schema gaps. How AI engines pick sources →

AEO rankings move month to month

AI engines re-crawl and re-rank on shorter cycles than classical search. We re-audit every brand on this list at least every 90 days and refresh this page automatically. How AI search ranking works →

Run an AEO audit on your own regulatory affairs consultancies brand

The brands above were curated from public market-leader lists. Want the same answer engine optimisation measurement against your own brand — including the queries you appear on, which competitors get named instead, and a prioritised fix list? Run a free preview.

Audit your regulatory affairs consultancies brand → Browse all AEO rankings Methodology →

Frequently asked about AEO for regulatory affairs consultancies

Who leads AI visibility in regulatory affairs consultancies?

ProPharma leads with a composite score of 53.8, driven by 50.0% visibility and 62.5% citation rate, both far above the category average of 6.2%.

What is the average AI visibility for regulatory affairs consultancies?

Both average visibility and average citation rate sit at 6.2%, indicating that most brands in the 20-brand dataset have near-zero presence in Google AI Mode responses.

Which brands are cited by AI but not named in responses?

MCRA has a 25.0% citation rate with 0.0% visibility, and Freyr Solutions has a 12.5% citation rate with 0.0% visibility, meaning both are referenced as sources without being surfaced by name.

What sources does Google AI Mode anchor on for regulatory affairs consultancy queries?

The top cited sources include biobostonconsulting.com, elexes.com, jjccgroup.org, propharmagroup.com, lachmanconsultants.com, umbrex.com, freyrsolutions.com, and linkedin.com, a mix of niche specialists and larger firms.

Which brands have lost AI visibility recently in this category?

NAMSA and Pharmalex each dropped three rank positions and lost 12.5 visibility points, falling from 12.5% visibility to 0.0% in the most recent period.

Is there a brand with high visibility but no citations in regulatory affairs?

IQVIA has 37.5% visibility but a 0.0% citation rate, the starkest example of a brand that appears in AI responses without its domain being cited as a source.